Young Innovators: Advancing gene therapy for skin cancer

University of Saskatchewan pharmacy post-doctoral researcher Mays Al-Dulaymi is developing a tiny chemical compound that holds promise for improving gene therapy for skin cancer and other genetic skin disorders.
One of the deadliest skin cancers, melanoma may be caused by overexposure to ultraviolet radiation from the sun or artificial sources such as tanning beds and sunlamps. The Melanoma Network of Canada reports that lifetime risk for developing melanoma has increased to one in 63 people tod